A Study to Evaluate INCB099280 in Participants With Select Solid Tumors Who Are Immune Checkpoint Inhibitor Naive
Clinical trial NCT05879822 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05879822
- Sponsor
- Incyte Corporation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-30
- Primary completion
- 2026-07-22
- Enrollment
- 73
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.